Enovis Corp (ENOV)

NYSE
Currency in USD
Disclaimer
51.65
-0.23(-0.44%)
Closed
After Hours
51.650.00(0.00%)
Day's Range
51.5152.29
52 wk Range
43.8866.71
Prev. Close
51.88
Open
51.88
Day's Range
51.51-52.29
52 wk Range
43.88-66.71
Volume
234,233
Average Vol. (3m)
352,298
1-Year Change
4.83%
Shares Outstanding
54,539,676
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
68.80
Upside +33.20%

People Also Watch

68.09
CVLT
+0.64%
134.58
ROG
-1.92%
62.87
RBA
-0.24%
36.44
VRT
+0.33%

Enovis Corp Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Income Statement